Computer & Information Technology

Swiss startup creates modular device for on-demand cell therapy manufacturing

Switzerland-based Limula today announced a raise of $6.8mn (€6.2mn) to further develop its technology, which aims to automate cell therapy manufacturing. Gene and cell therapies have emerged as a promising treatment for life-threatening or difficult-to-manage diseases such as cancer, Parkinson’s, and Alzheimer’s. Such therapies place healthy genes and cells into…
Read More

Action restricted!